These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3940838)

  • 1. [Embryonal malformation following etretinate therapy of Darier's disease in the mother].
    Kietzmann H; Schwarze I; Grote W; Ravens U; Jänig U; Harms D
    Dtsch Med Wochenschr; 1986 Jan; 111(2):60-2. PubMed ID: 3940838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Teratogenic effects of etretinate in humans].
    Happle R; Traupe H; Bounameaux Y; Fisch T
    Dtsch Med Wochenschr; 1984 Sep; 109(39):1476-80. PubMed ID: 6479047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of dyskeratosis follicularis Darier with the retinoic acid derivative Ro 10-9359 (Tigason).
    Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H
    Dermatologica; 1981; 163(2):164-8. PubMed ID: 7286356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malformation of fetus conceived 4 months after termination of maternal etretinate treatment.
    Grote W; Harms D; Jänig U; Kietzmann H; Ravens U; Schwarze I
    Lancet; 1985 Jun; 1(8440):1276. PubMed ID: 2860474
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic treatment of Darier's disease with an oral retinoic acid derivative Ro 10-9359 Tigason.
    Greig DE; Wishart J; Hodge JL
    N Z Med J; 1981 Aug; 94(689):99-100. PubMed ID: 6944653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of an aromatic retinoid, Tigason (etretinate), in the treatment of Darier's disease.
    Burge SM; Wilkinson JD; Miller AJ; Ryan TJ
    Br J Dermatol; 1981 Jun; 104(6):675-9. PubMed ID: 7248178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excessive cerumen production due to the aromatic retinoid Tigason in a patient with Darier's disease.
    Kramer M
    Acta Derm Venereol; 1982; 62(3):267-8. PubMed ID: 6179378
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of dyskeratosis follicularis (Darier's disease) with aromatic retinoid].
    Rubisz-Brzezińska J
    Przegl Dermatol; 1987; 74(6):443-8. PubMed ID: 3330247
    [No Abstract]   [Full Text] [Related]  

  • 9. Etretinate embryotoxicity 7 months after discontinuation of treatment.
    Verloes A; Dodinval P; Koulischer L; Lambotte R; Bonnivert J
    Am J Med Genet; 1990 Nov; 37(3):437-8. PubMed ID: 2260582
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dyskeratosis follicularis vegetans (Darier disease)--therapy with the aromatic retinoid RO 10-9359 (Tigason) in combination with systemic photochemotherapy (RePUVA)].
    Sönnichsen N; Brenke A; Diezel W
    Dermatol Monatsschr; 1982 Aug; 168(8):520-2. PubMed ID: 7173474
    [No Abstract]   [Full Text] [Related]  

  • 11. Darier's disease--dyskeratosis follicularis.
    Deroo H; Van Hecke E; Cuelenaere C; Kudsi S
    Dermatologica; 1990; 180(3):191. PubMed ID: 2340936
    [No Abstract]   [Full Text] [Related]  

  • 12. Teratogenic risk with etretinate and acitretin treatment.
    Geiger JM; Baudin M; Saurat JH
    Dermatology; 1994; 189(2):109-16. PubMed ID: 8075435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoid-induced haemorrhagic bullae in Darier's disease.
    Gebauer K; Holgate C; Navaratnam A
    Australas J Dermatol; 1990; 31(2):99-103. PubMed ID: 2095739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Penile agenesis and syndrome of multiple abnormalities associated with the ingestion of retinoic acid by the mother].
    Martínez Tallo ME; Galán Gómez E; Cordero Carrasco JL; Hidalgo Barquero EH; Campo Sampedro FM; Cardesa García JJ
    An Esp Pediatr; 1989 Oct; 31(4):399-400. PubMed ID: 2627062
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinico-morphological variants and problems of therapy of Darier's keratosis follicularis].
    Kalamkarian AA; Chistiakova IA; Getling ZM
    Vestn Dermatol Venerol; 1988; (4):4-7. PubMed ID: 3414166
    [No Abstract]   [Full Text] [Related]  

  • 16. [Efficacy and risks of topical 5-fluorouracil in Darier's disease].
    Le Bidre E; Delage M; Celerier P; De Muret A; Lorette G
    Ann Dermatol Venereol; 2010; 137(6-7):455-9. PubMed ID: 20620575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eczema herpeticum in a patient with Darier's disease during treatment with etretinate.
    Verner E; Shteinfeld M; Zuckerman F
    J Am Acad Dermatol; 1985 Oct; 13(4):678-80. PubMed ID: 4078062
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of follicular dyskeratosis (Darier's disease) with aromatic vitamin A].
    Mária W; Miklós S
    Orv Hetil; 1981 Mar; 122(9):522-4. PubMed ID: 7290698
    [No Abstract]   [Full Text] [Related]  

  • 19. [Children born of leukemic parents. Apropos of 23 children].
    Marradi P; Schaison G; Alby N; Berger R; Jacquillat C; Boiron M
    Nouv Rev Fr Hematol (1978); 1982; 24(2):75-80. PubMed ID: 7111016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparison of acitretin and etretinate in the treatment of Darier's disease.
    Christophersen J; Geiger JM; Danneskiold-Samsoe P; Kragballe K; Larsen FG; Laurberg G; Serup J; Thomsen K
    Acta Derm Venereol; 1992; 72(2):150-2. PubMed ID: 1350407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.